Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma

Urologia Internationalis

Volumn 79, Issue 1, 2007, Pages 41-43

  Merseburger, Axel S ^a   Hennenlotter, Joerg ^a   Stenzl, Arnulf ^a   Beger, Gundhild ^a   Rinnab, Ludwig ^b   Kuczyk, Markus A ^a   Kuefer, Rainer ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Cathepsin D; Enzyme immunoassay; Renal cell cancer

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; LYMPH NODE; MALE; METASTASIS; PRIORITY JOURNAL; SEX DIFFERENCE; VALIDITY;

AGED; CARCINOMA, RENAL CELL; CATHEPSIN D; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 34447329564     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102912     Document Type: Article

References (15)

1. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002;21:5951-5955.
2. Maurizi M, Almadori G, Cadoni G, Scambia G, Ottaviani F, Ferrandina G, Paludetti G, D'Abramo G, Mancuso S: Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis. Int J Cancer 1996;69:105-109.
3. Moul JW, Maygarden SJ, Ware JL, Mohler JL, Maher PD, Schenkman NS, Ho CK: Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy. J Urol 1996;155:982-985.
4. Theodoropoulos GE, Lazaris AC, Panoussopoulos D, Davaris P, Golematis BC: Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma. J Surg Oncol 1995;58:176-183.
5. Winstanley JH, Leinster SJ, Cooke TG, Westley BR, Platt-Higgins AM, Rudland PS: Prognostic significance of cathepsin-D in patients with breast cancer. Br J Cancer 1993;67:767-772.
6. Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S: Evaluation of serum cathepsin B and D in relation to clinico-pathological staging of colorectal cancer. World J Gastroenterol 2005;11:4225-4229.
7. Merseburger AS, Hennenlotter J, Simon P, Ohneseit PA, Kuehs U, Kruck S, Koch E, Vogel U, Stenzl A, Kuczyk MA: Cathepsin D expression in renal cell cancer - clinical implications. Eur Urol 2005;48:519-526.
8. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663.
9. Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N, Kallioniemi OP: Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 1993;11:36-43.
10. Leto G, Tumminello FM, Pizzolanti G, Montalto G, Soresi M, Ruggeri I, Gebbia N: Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis. Eur J Clin Chem Clin Biochem 1996;34:555-560.
11. Cherry JP, Mordente JA, Chapman JR, Choudhury MS, Tazaki H, Mallouh C, Konno S: Analysis of cathepsin D forms and their clinical implications in human prostate cancer. J Urol 1998;160:2223-2228.
12. Hara I, Miyake H, Yamanaka K, Hara S, Kamidono S: Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol Rep 2002;9:1379-1383.
13. Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K: Expression of sialyl Lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res 2005;25:1615-1622.
14. Wozniak A, Mila-Kierzenkowska C, Schachtschabel DO, Wozniak B, Rozwodowska M, Drewa T, Drewa S, Sir J, Sir I, Maciak R, Krzyzynska-Malinowska E: Activity of cathepsin D and α(1)-antitrypsin in the blood serum of patients with mammary carcinoma. Exp Oncol 2005;27:233-237.
15. Li SA, Liao DZ, Yazlovitskaya EM, Pantazis CG, Li JJ: Induction of cathepsin D protein during estrogen carcinogenesis: possible role in estrogen-mediated kidney tubular cell damage. Carcinogenesis 1997;18:1375-1380.